Citation Impact
Citing Papers
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
2009 Standout
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.
1998 Standout
Osteoarthritis year in review 2019: epidemiology and therapy
2020 Standout
Carboplatin as a Radiation Sensitizer in Locally Advanced Cervical Cancer: A Pilot Study
1997
Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer
1999 Standout
Cancer and the prothrombotic state
2002
Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL
2004
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
2009 Standout
Hydroxychloroquine: From Malaria to Autoimmunity
2011 Standout
Treatment of Non-small Cell Lung Cancer-Stage IIIA
2007
Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer: Failure patterns by cell type in rtog 88-08/ECOG 4588
1997
Radiation pneumonitis and early circulatory cytokine markers
2002
Amifostine in clinical oncology: current use and future applications
2002
Pulmonary embolism: a frequent cause of acute fatality after lung resection
1996
Pathogenesis of Thrombosis in Patients with Malignancy
2001
Malignancies, Prothrombotic Mutations, and the Risk of Venous Thrombosis
2005 Standout
Application of Curdlan to Controlled Drug Delivery. I. The Preparation and Evaluation of Theophylline-Containing Curdlan Tablets
1992
Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma
1995 Standout
Treatment of Non-Hodgkin's Lymphoma
1993
Prevention of VTE in Nonsurgical Patients
2012 Standout
Interleukin (IL)-1A and IL-6: Applications to the predictive diagnostic testing of radiation pneumonitis
2005
Chemical and Instrumental Approaches to Treat Hyperpigmentation
2003 Standout
A Standardized Protocol for Assessing Regulators of Pigmentation
1999
Locally advanced non-small cell lung cancer: Do we know the questions?
1996
Gemcitabine and paclitaxel associated pneumonitis in non-small cell lung cancer
2000
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017 Standout
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
2010 Standout
Prevention of VTE in Nonorthopedic Surgical Patients
2012 Standout
The pathobiology of mucositis
2004 Standout
The efficacy and safety of low-dose radiotherapy on pain and functioning in patients with osteoarthritis: a systematic review
2015
Duration of Prophylaxis against Venous Thromboembolism with Enoxaparin after Surgery for Cancer
2002 Standout
Microbially controlled drug delivery to the colon
1990
Prevention of Venous Thromboembolism
2004 Standout
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
Mechanisms of Hypercoagulation in Malignancy and during Chemotherapy
1998
Prevention of Venous Thromboembolism
2008 Standout
Targeting autophagy in cancer
2017 Standout
Revisions in the International System for Staging Lung Cancer
1997 Standout
Gamma-scintigraphic study of the gastrointestinal transit and in vivo dissolution of a controlled release diclofenac sodium formulation in xanthan gum matrices
2000
The use of quinacrine (Atabrine) in rheumatic diseases: A reexamination
1989
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
2008 Standout
Modification of the sample size and the schedule of interim analyses in survival trials based on data inspections
2001
Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL
2004
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
2009 Standout
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
Long-Term Results of the R-CHOP Study in the Treatment of Elderly Patients With Diffuse Large B-Cell Lymphoma: A Study by the Groupe d'Etude des Lymphomes de l'Adulte
2005 Standout
Rituximab-CHOP Versus CHOP Alone or With Maintenance Rituximab in Older Patients With Diffuse Large B-Cell Lymphoma
2006 Standout
Diagnosis and Management of Cerebral Venous Thrombosis
2011 Standout
Main properties and current applications of some polysaccharides as biomaterials
2007 Standout
Radiosensitization With Carboplatin for Patients With Unresectable Stage III Non–Small-Cell Lung Cancer: A Phase III Trial of the Cancer and Leukemia Group B and the Eastern Cooperative Oncology Group
1999
Adding Chloroquine to Conventional Treatment for Glioblastoma Multiforme
2006
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
2008 Standout
Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb nonsmall cell lung cancer: A meta‐analysis
1996
Chitosan Chemistry and Pharmaceutical Perspectives
2004 Standout
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Regulation of Mammalian Autophagy in Physiology and Pathophysiology
2010 Standout
Works of R. Pfab being referenced
Randomised comparison of CHOEP versus alternating hCHOP/IVEP for high-grade non-Hodgkin's lymphomas: Treatment results and prognostic factor analysis in a multi-centre trial
1994
CHOP-VP16 chemotherapy and involved field irradiation for high grade non-Hodgkin's lymphomas: a phase II multicentre study
1989
Carboplatin and Simultaneous Radiation in the Treatment of Stage III A/B Non-Small Cell Lung Cancer
1992
Severe lymphocytopenia and interstitial pneumonia in patients treated with paclitaxel and simultaneous radiotherapy for non-small-cell lung cancer.
1996
Preclincal and clinical experience with cisplatin and carboplatin and simultaneous radiation in non-small cell lung cancer
1992
Sequential versus alternating chemotherapy for high grade non‐hodgkin's lymphomas: A randomized multicentre trial
1991
Activation of coagulation and fibrinolysis in patients with lung cancer
1993
Augmentation by L-dopa of growth inhibition and melanin formation of X-irradiated Harding-Passey melanoma cells in culture.
1988
Measurement of theophylline absorption from different regions of the gastro-intestinal tract using a remote controlled durg delivery device
1986
[Ultrastructural studies of the effect of x-rays and quinacrine (Atebrin) or chloroquine (Resochin)--alone or in combination--on Harding-Passey melanoma cells in monolayer culture].
1985
Radiotherapy alone versus chemotherapy with ifosfamide/vindesine followed by radiotherapy in unresectable locally advanced non-small cell lung cancer.
1994
[Influence of x-rays and quinacrine (atebrine) or chloroquine (resochine)--alone or in combination--on growth and melanin formation of Harding-Passey melanoma cells in monolayer culture].
1982
[Radiotherapy of degenerative inflammatory joint diseases in the elderly. A worthwhile therapeutic measure].
1995